BHC BAUSCH HEALTH COS INC revenue, earnings and financials

For the quarter ended June 30, 2026, BAUSCH HEALTH COS INC reported revenue of $2.85B (up 12.7% from a year earlier), net income of $258M and diluted EPS of $0.68; over the last four quarters revenue was $10.9B and net income −$1.10B; for the fiscal year ended December 2025 revenue was $10.3B, up 6.7% on the year before.

BHC annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $10.3B, gross profit n/a, operating income $1.81B, net income $157M (margin 1.5%), EPS $0.42
• Fiscal year ended Dec 2024: revenue $9.63B, gross profit n/a, operating income $1.55B, net income −$46.0M (margin -0.5%), EPS −$0.13
• Fiscal year ended Dec 2023: revenue $8.76B, gross profit n/a, operating income $963M, net income −$592M (margin -6.8%), EPS −$1.62
• Fiscal year ended Dec 2022: revenue $8.12B, gross profit n/a, operating income $454M, net income −$225M (margin -2.8%), EPS −$0.62
• Fiscal year ended Dec 2021: revenue $8.43B, gross profit n/a, operating income $450M, net income −$948M (margin -11.2%), EPS −$2.64

BHC quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $2.85B (up 12.7% year over year), net income $258M, EPS $0.68
• Quarter ended Mar 31, 2026: revenue $2.52B (up 11.7% year over year), net income −$1.42B, EPS −$3.82
• Quarter ended Dec 31, 2025 (from the annual report): revenue $2.80B (up 9.3% year over year), net income −$112M, EPS −$0.30
• Quarter ended Sep 30, 2025: revenue $2.68B (up 6.8% year over year), net income $179M, EPS $0.48
• Quarter ended Jun 30, 2025: revenue $2.53B (up 5.3% year over year), net income $148M, EPS $0.40
• Quarter ended Mar 31, 2025: revenue $2.26B (up 4.9% year over year), net income −$58.0M, EPS −$0.16
• Quarter ended Dec 31, 2024 (from the annual report): revenue $2.56B (up 6.3% year over year), net income $93.0M, EPS $0.24
• Quarter ended Sep 30, 2024: revenue $2.51B (up 12.2% year over year), net income −$85.0M, EPS −$0.23
• Quarter ended Jun 30, 2024: revenue $2.40B (up 10.9% year over year), net income $10.0M, EPS $0.03
• Quarter ended Mar 31, 2024: revenue $2.15B (up 10.8% year over year), net income −$64.0M, EPS −$0.17
• Quarter ended Dec 31, 2023 (from the annual report): revenue $2.41B (up 9.8% year over year), net income −$39.0M, EPS −$0.11
• Quarter ended Sep 30, 2023: revenue $2.24B (up 9.4% year over year), net income −$378M, EPS −$1.03
• Quarter ended Jun 30, 2023: revenue $2.17B (up 10.2% year over year), net income $26.0M, EPS $0.07
• Quarter ended Mar 31, 2023: revenue $1.94B (up 1.4% year over year), net income −$201M, EPS −$0.55
• Quarter ended Dec 31, 2022 (from the annual report): revenue $2.19B (down 0.1% year over year), net income −$410M, EPS −$1.13
• Quarter ended Sep 30, 2022: revenue $2.05B (down 3.1% year over year), net income $399M, EPS $1.10
• Quarter ended Jun 30, 2022: revenue $1.97B (down 6.3% year over year), net income −$145M, EPS −$0.40
• Quarter ended Mar 31, 2022: revenue $1.92B (down 5.4% year over year), net income −$69.0M, EPS −$0.19
• Quarter ended Dec 31, 2021 (from the annual report): revenue $2.20B, net income $69.0M, EPS $0.21
• Quarter ended Sep 30, 2021: revenue $2.11B, net income $188M, EPS $0.52

BHC cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $1.40B, share buybacks n/a
• Fiscal year ended Dec 2024: operating cash flow $1.60B, share buybacks n/a
• Fiscal year ended Dec 2023: operating cash flow $1.03B, share buybacks n/a
• Fiscal year ended Dec 2022: operating cash flow −$728M, share buybacks n/a
• Fiscal year ended Dec 2021: operating cash flow $1.43B, share buybacks n/a

BHC balance sheet

• Jun 30, 2026: cash $1.83B, total assets $24.8B, total liabilities $25.6B, shareholders' equity −$1.77B, long-term debt $19.9B
• Mar 31, 2026: cash $1.30B, total assets $24.5B, total liabilities $25.6B, shareholders' equity −$2.06B, long-term debt $19.9B
• Dec 31, 2025: cash $1.31B, total assets $26.4B, total liabilities $26.0B, shareholders' equity −$554M, long-term debt $20.6B
• Sep 30, 2025: cash $1.31B, total assets $26.8B, total liabilities $26.5B, shareholders' equity −$565M, long-term debt $20.5B
• Jun 30, 2025: cash $1.73B, total assets $27.3B, total liabilities $27.1B, shareholders' equity −$764M, long-term debt $20.9B
• Mar 31, 2025: cash $1.13B, total assets $26.4B, total liabilities $26.7B, shareholders' equity −$1.18B, long-term debt $21.2B
• Dec 31, 2024: cash $1.18B, total assets $26.5B, total liabilities $26.8B, shareholders' equity −$1.28B, long-term debt $18.9B
• Sep 30, 2024: cash $719M, total assets $26.5B, total liabilities $26.8B, shareholders' equity −$1.17B, long-term debt $21.1B

What is BHC's revenue?

BAUSCH HEALTH COS INC reported $10.9B of revenue over its last four quarters, through June 30, 2026.

Is BHC profitable?

No. BAUSCH HEALTH COS INC lost $1.10B over the last four quarters.

What is BHC's EPS?

Diluted earnings per share over the last four quarters were −$2.96; $0.68 in the latest quarter.

BHC ownership and insider trades · All stocks